Skip to main content
Clinical Trials/NCT06446492
NCT06446492CompletedNot Applicable

Impact of Video-Enhanced Consent on Informed Decision-Making for Parents of Extremely Preterm Infants Eligible for the ViDES Study: A Randomized Controlled Trial

The University of Texas Health Science Center, Houston2 sites in 1 country83 target enrollmentStarted: July 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
83
Locations
2
Primary Endpoint
Participants' understanding of the ViDES study as assessed by a questionnaire

Study Overview

Brief Summary

This pilot randomized controlled trial evaluates the impact of video-enhanced consent compared to the usual approach. The investigators aim to assess if video-enhanced consent empowers decision-making and improves understanding in parents considering participation in the ViDES study, which investigates the effectiveness of Vitamin D supplementation in extremely preterm infants (the ViDES study is separately registered as NCT05459298).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Parents/legal guardians of extremely preterm infants (<28 weeks gestational age or <1000 g birth weight) admitted to the Neonatal Intensive Care Unit at Children's Memorial Hermann hospital that qualify for the ViDES study (ViDES study is separately registered as NCT05459298)

Exclusion Criteria

  • Parents/legal guardians deaf or blind
  • Parents/legal guardians unable to consent for the VIDES study

Outcomes

Primary Outcomes

Participants' understanding of the ViDES study as assessed by a questionnaire

Time Frame: Within 48 hours of the intervention

The questionnaire assesses recall of possible benefits and risks of participation.

Participants' satisfaction with consent approach as assessed by a questionnaire

Time Frame: Within 48 hours of the intervention

The questionnaire assesses satisfaction with ability to ask questions and decision time.

ViDES trial consent rate

Time Frame: Within 1 week of the intervention

Participant's opinions related to participation in research as assessed by a questionnaire

Time Frame: Within 48 hours of the intervention

The questionnaire assesses participant's opinions related to participation in research and research being part of the care of infants.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Maria del Mar Romero López

Assistant Professor

The University of Texas Health Science Center, Houston

Study Sites (2)

Loading locations...

Similar Trials